IND Application Filed for Nimacimab, A Potential Treatment for Renal Diseases
On May 28th, biopharmaceutical company Bird Rock Bio filed an IND application to perform a Phase II clinical study to determine the efficacy and tolerability of nimacimab. The company hopes…